PharmiWeb
FDA approves Roche’s Vabysmo prefilled syringe (PFS) for three leading causes of vision loss
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the United States Food and Drug Administration (US FDA) has approved the Vabysmo® (faricimab) 6.0 mg single-dose prefilled syringe (PFS) for ...
6 hours ago